- Home
- CYBN vs EFSI Comparison
CYBN vs EFSI Comparison
Compare CYBN & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- EFSI
- Stock Information
- Founded
- CYBN 2019
- EFSI 1881
- Country
- CYBN Canada
- EFSI United States
- Employees
- CYBN N/A
- EFSI N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- EFSI Major Banks
- Sector
- CYBN Health Care
- EFSI Finance
- Exchange
- CYBN Nasdaq
- EFSI Nasdaq
- Market Cap
- CYBN 176.0M
- EFSI 180.1M
- IPO Year
- CYBN N/A
- EFSI N/A
- Fundamental
- Price
- CYBN $7.11
- EFSI $36.12
- Analyst Decision
- CYBN Strong Buy
- EFSI Strong Buy
- Analyst Count
- CYBN 3
- EFSI 2
- Target Price
- CYBN $85.00
- EFSI $39.50
- AVG Volume (30 Days)
- CYBN 351.0K
- EFSI 14.7K
- Earning Date
- CYBN 08-13-2025
- EFSI 07-24-2025
- Dividend Yield
- CYBN N/A
- EFSI 3.55%
- EPS Growth
- CYBN N/A
- EFSI N/A
- EPS
- CYBN N/A
- EFSI 1.85
- Revenue
- CYBN N/A
- EFSI $61,734,000.00
- Revenue This Year
- CYBN N/A
- EFSI $11.86
- Revenue Next Year
- CYBN N/A
- EFSI $12.83
- P/E Ratio
- CYBN N/A
- EFSI $19.48
- Revenue Growth
- CYBN N/A
- EFSI N/A
- 52 Week Low
- CYBN $4.81
- EFSI $28.70
- 52 Week High
- CYBN $13.88
- EFSI $36.93
- Technical
- Relative Strength Index (RSI)
- CYBN 45.43
- EFSI 79.03
- Support Level
- CYBN $6.36
- EFSI $34.76
- Resistance Level
- CYBN $7.75
- EFSI $35.42
- Average True Range (ATR)
- CYBN 0.34
- EFSI 0.60
- MACD
- CYBN -0.04
- EFSI 0.16
- Stochastic Oscillator
- CYBN 51.95
- EFSI 92.49
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.